HNL Lab Medicine announced an investment in a new digital pathology initiative. HNL Lab Medicine has selected solutions from Proscia, a digital pathology software company, and Leica Biosystems, a manufacturer of high-quality imaging hardware, to establish an advanced digital pathology practice. This investment will enhance the lab’s diagnostic capabilities, improve efficiency, and ultimately provide better patient care.
The initiative combines Proscia’s innovative digital pathology software platform Concentriq Dx and Leica Biosystems’ scanner hardware. Proscia’s Concentriq Dx drives routine workflows, streamlines collaboration and is designed for realizing the promise of pathology’s AI-powered future. Combined with Leica Biosystems’ innovative high throughput scanner hardware, this solution will enable HNL Lab Medicine’s pathologists to get to the correct diagnosis more efficiently, benefiting both patients and healthcare providers.
